Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3946610 | Gynecologic Oncology | 2006 | 10 Pages |
Abstract
These findings demonstrate that PEITC exhibits cytotoxicity towards OVCAR-3 cells and induces apoptosis via caspase-9 and -3 pathways. PEITC inhibits Akt, ERK1/2 survival signaling, and c-Myc while simultaneously activating pro-apoptotic p38 and JNK1/2. Systematic preclinical and clinical trials with PEITC in ovarian cancer are indicated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
K.S. Satyan, Narasimha Swamy, Don S. Dizon, Rakesh Singh, Cornelius O. Granai, Laurent Brard,